Overview
Investment management firm offering financial services.
Deals ยท 12mo
2
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Calyxo | Apr 2026Participated | $40 MSeries F | |
Artios Pharma | Nov 2025Participated | $115 MSeries D | |
Affinia Therapeutics | Oct 2025Participated | $40 MSeries C | |
OrganOx | Feb 2025Participated | $142 MOther Equity | |
Sirona Medical | Nov 2024Led | $42 MSeries C | |
Aktis Oncology | Sep 2024Participated | $175 MSeries B | |
858 Therapeutics | Sep 2024Led | $50 MSeries B | |
Helaina | Sep 2024Led | $45 MSeries B | |
Endeavor BioMedicines | Apr 2024Participated | $133 MSeries C | |
TORL BioTherapeutics | Apr 2024Participated | $158 MSeries B | |
Calyxo | Dec 2023Led | $50 MSeries D | |
MBrace Therapeutics | Nov 2023Participated | $85 MSeries B | |
Calyxo | Apr 2026Participated | $40 MSeries F | |
Artios Pharma | Nov 2025Participated | $115 MSeries D | |
Affinia Therapeutics | Oct 2025Participated | $40 MSeries C | |
OrganOx | Feb 2025Participated | $142 MOther Equity | |
Sirona Medical | Nov 2024Led | $42 MSeries C | |
Aktis Oncology | Sep 2024Participated | $175 MSeries B | |
858 Therapeutics | Sep 2024Led | $50 MSeries B | |
Helaina | Sep 2024Led | $45 MSeries B | |
Endeavor BioMedicines | Apr 2024Participated | $133 MSeries C | |
TORL BioTherapeutics | Apr 2024Participated | $158 MSeries B | |
Calyxo | Dec 2023Led | $50 MSeries D | |
MBrace Therapeutics | Nov 2023Participated | $85 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 2 |
| Series B | 3 | 15 |
| Series C+ | 5 | 13 |
| Other Equity | 1 | 4 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jun '20 | 2 |
| Jul '20 | 0 |
| Aug '20 | 1 |
| Sep '20 | 1 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 1 |
| Mar '21 | 4 |
| Apr '21 | 0 |
| May '21 | 2 |
| Jun '21 | 0 |
| Jul '21 | 3 |
| Aug '21 | 3 |
| Sep '21 | 0 |
| Oct '21 | 1 |
| Nov '21 | 1 |
| Dec '21 | 2 |
| Jan '22 | 1 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 2 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 2 |
| Jul '23 | 0 |
| Aug '23 | 1 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 1 |
| Dec '23 | 1 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 2 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 3 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 40 |
| AI & Machine Learning | 3 |
| Networks, Cloud & Communication | 2 |
| Enterprise Software | 2 |
| Manufacturing | 2 |
| Consumer & Lifestyle | 2 |
| Marketing & Advertising | 1 |
| Clean Energy & Sustainability | 1 |
| Professional Services | 1 |
| Data, Analytics & IT | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 6 |
| $50M-$100M | 13 |
| $100M-$250M | 23 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 5 of 5 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 35 |
| Europe | 5 |
| Canada | 1 |
| Japan | 1 |
| China | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Janus Henderson Investors | 13 |
| RA Capital Management | 10 |
| Perceptive Advisors | 8 |
| Ally Bridge Group | 7 |
| Surveyor Capital | 7 |
| Casdin Capital | 6 |
| Omega Funds | 6 |
| OrbiMed | 6 |
| Piper Heartland Healthcare Capital | 6 |
| Alexandria Venture Investments | 5 |
| Invus | 5 |
| Longitude Capital | 5 |
| Deep Track Capital | 4 |
| EcoR1 Capital | 4 |
| Farallon Capital Management | 4 |
| Fidelity Management & Research Company | 4 |
| Logos Capital | 4 |
| Novartis | 4 |
| Redmile Group | 4 |
| Rock Springs Capital | 4 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 9 | 21% |
| Participating | 34 | 79% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 5 | 56% |
| Co-led | 4 | 44% |
Team
Co-Managing Partner, Co-Founder